Recent Publications

• 1. Ajay PS
  2. NeMoyer R
  3. Goyal S
  4. Switchenko JM
  5. Lin Y
  6. Jabbour SK
  7. Carpizo DR
  8. Paulos CM
  9. Kennedy TJ
  10. Shah MM
  Does non-metastatic gastric cancer of the cardia warrant a different treatment strategy?; Journal of surgical oncology. 2023 Apr 10.
• 1. Ghaddar B
  2. Biswas A
  3. Harris C
  4. Omary MB
  5. Carpizo DR
  6. Blaser MJ
  7. De S
  Tumor microbiome links cellular programs and immunity in pancreatic cancer.; Cancer cell; Vol 40(10), pp. 1240-1253.e5. 2022 Oct 10.
• 1. Melucci AD
  2. Chacon AC
  3. Burchard PR
  4. Tsagkalidis V
  5. Casabianca AS
  6. Goyal S
  7. Switchenko JM
  8. Kooby DA
  9. Staley CA
  10. Carpizo DR
  11. Shah MM
  The Impact of Carbohydrate Antigen 19-9 on Survival in Patients with Clinical Stage I and II Pancreatic Cancer.; Annals of surgical oncology. 2022 Sep 19.
• 1. Melucci AD
  2. Carpizo DR
  3. Shah MM
  ASO Author Reflections: Pretreatment CA 19-9 Threshold of 98 U/mL is a Reasonable Cutoff for Prognostication of Clinical Stage I and II Pancreatic Cancer.; Annals of surgical oncology. 2022 Sep 10.
• 1. Melucci AD
  2. Chacon AC
  3. Burchard PR
  4. Tsagkalidis V
  5. Casabianca AS
  6. Goyal S
  7. Switchenko JM
  8. Kooby DA
  9. Staley CA
  10. Carpizo DR
  11. Shah MM
  ASO Visual Abstract: The Impact of Carbohydrate Antigen 19-9 on Survival in Patients with Clinical Stage I and II Pancreatic Cancer.; Annals of surgical oncology. 2022 Sep 10.
• 1. Ajay PS
  2. Casabianca A
  3. Shah MM
  4. Carpizo DR
  Reply to: Radical treatment for stage IV gallbladder cancers: Is surgery a worthwhile exercise in advanced cancers?; European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2022 Aug 27.
• 1. Ajay PS
  2. Tsagkalidis V
  3. Casabianca A
  4. Burchard PR
  5. Melucci AD
  6. Chacon A
  7. Goyal S
  8. Switchenko JM
  9. Kooby DA
  10. Carpizo DR
  11. Shah MM
  A review of hepatic epithelioid hemangioendothelioma-Analyzing patient characteristics and treatment strategies.; Journal of surgical oncology. 2022 Aug 17.
• 1. Casabianca AS
  2. Tsagkalidis V
  3. Burchard PR
  4. Chacon A
  5. Melucci A
  6. Reitz A
  7. Swift DA
  8. McCook AA
  9. Switchenko JM
  10. Shah MM
  11. Carpizo DR
  Surgery in combination with systemic chemotherapy is associated with improved survival in stage IV gallbladder cancer.; European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2022 Jun 22.
• 1. Casabianca AS
  2. Hernandez Caballero AI
  3. Thornburg LL
  4. Carpizo D
  Management of hepatic haemangioma in pregnancy.; BMJ case reports; Vol 15(6). 2022 Jun 10.
• 1. Greco SH
  2. Chao JC
  3. Heath NG
  4. Lin Y
  5. Gall VA
  6. Grandhi MS
  7. Kennedy TJ
  8. Carpizo DR
  9. Alexander HR
  10. Langan RC
  11. August DA
  Surgery is Associated With Improved Overall Survival in Patients With Metastatic Gastric Cancer: A National Cancer Database Analysis.; The American surgeon. 2022 Jun 01.
• 1. Burchard PR
  2. Dave YA
  3. Loria AP
  4. Parikh NB
  5. Pineda-Solis K
  6. Ruffolo LI
  7. Strawderman M
  8. Schoeniger LO
  9. Galka E
  10. Tomiyama K
  11. Orloff MS
  12. Carpizo DR
  13. Linehan DC
  14. Hernandez-Alejandro R
  Early postoperative ERAS compliance predicts decreased length of stay and complications following liver resection.; HPB : the official journal of the International Hepato Pancreato Biliary Association. 2022 Jan 25.
• 1. Burchard PR
  2. Chacon AC
  3. Melucci A
  4. Casabianca AS
  5. Goyal S
  6. Switchenko JM
  7. Maithel SK
  8. Kooby DA
  9. Carpizo DR
  10. Shah MM
  Defining the role of systemic therapy in resectable pancreatic acinar cell carcinoma.; Journal of surgical oncology. 2022 Jan 07.
• 1. Ha JH
  2. Prela O
  3. Carpizo DR
  4. Loh SN
  p53 and Zinc: A Malleable Relationship.; Frontiers in molecular biosciences; Vol 9. 2022.
• 1. Ha JH
  2. Yu X
  3. Carpizo DR
  4. Loh SN
  Urea Denaturation, Zinc Binding, and DNA Binding Assays of Mutant p53 DNA-binding Domains and Full-length Proteins.; Bio-protocol; Vol 11(20). 2021 Oct 20.
• 1. Carpizo DR
  2. Harris CR
  Genetic Drivers of Ileal Neuroendocrine Tumors.; Cancers; Vol 13(20). 2021 Oct 10.
• 1. Ciner AT
  2. Hochster HS
  3. August DA
  4. Carpizo DR
  5. Spencer KR
  Delayed cytokine release syndrome after neoadjuvant nivolumab: a case report and literature review.; Immunotherapy. 2021 Jul 21.
• 1. Gilleran JA
  2. Yu X
  3. Blayney AJ
  4. Bencivenga AF
  5. Na B
  6. Augeri DJ
  7. Blanden AR
  8. Kimball SD
  9. Loh SN
  10. Roberge JY
  11. Carpizo DR
  Benzothiazolyl and Benzoxazoyl Hydrazones Function as Zinc Metallochaperones to Reactivate Mutant p53.; Journal of medicinal chemistry. 2021 Feb 04.
• 1. Meltzer RS
  2. Kooby DA
  3. Switchenko JM
  4. Datta J
  5. Carpizo DR
  6. Maithel SK
  7. Shah MM
  ASO Visual Abstract: Does Major Pancreatic Surgery have Utility for Nonagenarians with Pancreas Cancer?; Annals of surgical oncology. 2021 Jan 07.
• 1. Greco SH
  2. August DA
  3. Shah MM
  4. Chen C
  5. Moore DF
  6. Masanam M
  7. Turner AL
  8. Jabbour SK
  9. Javidian P
  10. Grandhi MS
  11. Kennedy TJ
  12. Alexander HR
  13. Carpizo DR
  14. Langan RC
  Neoadjuvant therapy is associated with lower margin positivity rates after Pancreaticoduodenectomy in T1 and T2 pancreatic head cancers: An analysis of the National Cancer Database.; Surgery open science; Vol 3. 2021 Jan.
• 1. Blanden AR
  2. Yu X
  3. Blayney AJ
  4. Demas C
  5. Ha JH
  6. Liu Y
  7. Withers T
  8. Carpizo DR
  9. Loh SN
  Zinc shapes the folding landscape of p53 and establishes a pathway for reactivating structurally diverse cancer mutants.; eLife; Vol 9. 2020 Dec 02.
• 1. Meltzer RS
  2. Kooby DA
  3. Switchenko JM
  4. Datta J
  5. Carpizo DR
  6. Maithel SK
  7. Shah MM
  Does Major Pancreatic Surgery Have Utility in Nonagenarians with Pancreas Cancer?; Annals of surgical oncology. 2020 Nov 03.
• 1. Muaddi H
  2. D'Angelica M
  3. Wiseman JT
  4. Dillhoff M
  5. Latchana N
  6. Roke R
  7. Ko YJ
  8. Carpizo D
  9. Spencer K
  10. Fields RC
  11. Williams G
  12. Aucejo F
  13. Acevedo-Moreno LA
  14. Billingsley KG
  15. Walker BS
  16. Mayo SC
  17. Karanicolas PJ
  Safety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: A multicenter, retrospective cohort study.; Journal of surgical oncology. 2020 Oct 23.
• 1. Park KU
  2. Mamounas EP
  3. Katz MHG
  4. Unzeitig G
  5. Carpizo D
  6. You YN
  7. Francescatti A
  8. Hunt KK
  9. Boughey JC
  Clinical Trials for the Surgical Oncologist: Opportunities and Hurdles.; Annals of surgical oncology; Vol 27(7). 2020 Jul.
• 1. Kangas-Dick A
  2. Gall V
  3. Hilden P
  4. Turner A
  5. Greenbaum A
  6. Sesti J
  7. Paul S
  8. Carpizo D
  9. Kennedy T
  10. Sadaria Grandhi M
  11. Alexander HR
  12. Wang S
  13. Geffner S
  14. August D
  15. Langan RC
  Disparities in utilization of services for racial and ethnic minorities with hepatocellular carcinoma associated with hepatitis C.; Surgery; Vol 168(1). 2020 Jul.
• 1. Shah MM
  2. Meyer BI
  3. Rhee K
  4. NeMoyer RE
  5. Lin Y
  6. Tzeng CD
  7. Jabbour SK
  8. Kennedy TJ
  9. Nosher JL
  10. Kooby DA
  11. Maithel SK
  12. Carpizo DR
  Conditional survival analysis of hepatocellular carcinoma.; Journal of surgical oncology. 2020 Jun 10.
• 1. Shah MM
  2. NeMoyer RE
  3. Greco SH
  4. Chen C
  5. Moore DF
  6. Grandhi MS
  7. Langan RC
  8. Kennedy TJ
  9. Javidian P
  10. Jabbour SK
  11. Alexander HR
  12. August DA
  13. Carpizo DR
  Subcategorizing T1 Staging in Pancreatic Adenocarcinoma Predicts Survival in Patients Undergoing Resection: An Analysis of the National Cancer Database.; Journal of pancreatic cancer; Vol 6(1). 2020.
• 1. Khullar K
  2. Patel NM
  3. Anderson C
  4. Chundury A
  5. Carpizo D
  6. Feingold D
  7. Grandhi M
  8. Hochster H
  9. Jani K
  10. Kennedy T
  11. Langan R
  12. Spencer K
  13. August D
  14. Jabbour SK
  The Evolving Role of Radiotherapy in Locally Advanced Rectal Cancer and the Potential for Nonoperative Management.; Oncology & hematology review; Vol 16(1). 2020.
• 1. Contractor T
  2. Clausen R
  3. Harris G
  4. Rosenfeld J
  5. Carpizo D
  6. Tang L
  7. Harris C
  IGF2 drives formation of ileal neuroendocrine tumors in patients and mice.; Endocrine-related cancer. 2020 Jan 01.
• 1. Chi A
  2. Adams BE
  3. Sesti J
  4. Paul S
  5. Turner AL
  6. August D
  7. Carpizo D
  8. Kennedy T
  9. Grandhi M
  10. Alexander HR
  11. Libutti SK
  12. Geffner S
  13. Langan RC
  Outcomes Following Major Oncologic Operations for Non-AIDS-Defining Cancers in the HIV Population: A Matched Comparison to the General Population.; World journal of surgery; Vol 43(12). 2019 Dec.
• 1. Zaman S
  2. Yu X
  3. Bencivenga AF
  4. Blanden AR
  5. Liu Y
  6. Withers T
  7. Na B
  8. Blayney AJ
  9. Gilleran J
  10. Boothman DA
  11. Loh SN
  12. Kimball SD
  13. Carpizo DR
  Combinatorial Therapy of Zinc Metallochaperones with Mutant p53 Reactivation and Diminished Copper Binding.; Molecular cancer therapeutics; Vol 18(8). 2019 Aug.
• 1. Ali ND
  2. Donohue K
  3. Zandieh S
  4. Chen C
  5. Moore D
  6. Poplin E
  7. Shah MM
  8. Nosher J
  9. Gui B
  10. Jabbour SK
  11. Spencer K
  12. Carpizo DR
  Conditional Survival Analysis of Metastatic Colorectal Cancer Patients Living ≥24 Months: A Single Institutional Study.; American journal of clinical oncology; Vol 42(6). 2019 Jun.
• 1. Hasan O
  2. Greco S
  3. Kennedy T
  4. Carpizo D
  5. Kempf J
  6. Nosher J
  Aberrant arc between the common hepatic artery and a replaced right hepatic artery resulting in misperfusion in a patient with a hepatic arterial infusion pump.; Surgical and radiologic anatomy : SRA; Vol 41(3). 2019 Mar.
• 1. Dave YA
  2. Gupta A
  3. Shah MM
  4. Carpizo D
  Liver haematoma as a presentation of peliosis hepatis.; BMJ case reports; Vol 12(2). 2019 Feb 22.
• 1. Yu X
  2. Carpizo DR
  Flipping the "switch" on mutant p53 by zinc metallochaperones: how a brief pulse of zinc can reactivate mutant p53 to kill cancer.; Oncotarget; Vol 10(9). 2019 Jan 29.
• 1. Na B
  2. Yu X
  3. Withers T
  4. Gilleran J
  5. Yao M
  6. Foo TK
  7. Chen C
  8. Moore D
  9. Lin Y
  10. Kimball SD
  11. Xia B
  12. Ganesan S
  13. Carpizo DR
  Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation.; NPJ breast cancer; Vol 5. 2019.
• 1. Sayan M
  2. Yegya-Raman N
  3. Greco SH
  4. Gui B
  5. Zhang A
  6. Chundury A
  7. Grandhi MS
  8. Hochster HS
  9. Kennedy TJ
  10. Langan RC
  11. Malhotra U
  12. Rustgi VK
  13. Shah MM
  14. Spencer KR
  15. Carpizo DR
  16. Nosher JL
  17. Jabbour SK
  Rethinking the Role of Radiation Therapy in the Treatment of Unresectable Hepatocellular Carcinoma: A Data Driven Treatment Algorithm for Optimizing Outcomes.; Frontiers in oncology; Vol 9. 2019.
• 1. Langan RC
  2. Carpizo DR
  Modernizing the clinical risk score to more accurately predict survival following resection of colorectal liver metastases.; Translational gastroenterology and hepatology; Vol 4. 2019.
• 1. Yu X
  2. Kogan S
  3. Chen Y
  4. Tsang AT
  5. Withers T
  6. Lin H
  7. Gilleran J
  8. Buckley B
  9. Moore D
  10. Bertino J
  11. Chan C
  12. Kimball SD
  13. Loh SN
  14. Carpizo DR
  Zinc Metallochaperones Reactivate Mutant p53 Using an ON/OFF Switch Mechanism: A New Paradigm in Cancer Therapeutics.; Clinical cancer research : an official journal of the American Association for Cancer Research; Vol 24(18). 2018 Sep 15.
• 1. Gui B
  2. Weiner AA
  3. Nosher J
  4. Lu SE
  5. Foltz GM
  6. Hasan O
  7. Kim SK
  8. Gendel V
  9. Mani NB
  10. Carpizo DR
  11. Saad NE
  12. Kennedy TJ
  13. Zuckerman DA
  14. Olsen JR
  15. Parikh PJ
  16. Jabbour SK
  Assessment of the Albumin-Bilirubin (ALBI) Grade as a Prognostic Indicator for Hepatocellular Carcinoma Patients Treated With Radioembolization.; American journal of clinical oncology; Vol 41(9). 2018 Sep.
• 1. Yegya-Raman N
  2. Shah MM
  3. Grandhi MS
  4. Poplin E
  5. August DA
  6. Kennedy TJ
  7. Malhotra U
  8. Spencer KR
  9. Carpizo DR
  10. Jabbour SK
  Adjuvant therapeutic strategies for resectable pancreatic adenocarcinoma.; Annals of pancreatic cancer; Vol 1. 2018 Aug.
• 1. Weiner AA
  2. Gui B
  3. Newman NB
  4. Nosher JL
  5. Yousseff F
  6. Lu SE
  7. Foltz GM
  8. Carpizo D
  9. Lowenthal J
  10. Zuckerman DA
  11. Benson B
  12. Olsen JR
  13. Jabbour SK
  14. Parikh PJ
  Predictors of Survival after Yttrium-90 Radioembolization for Colorectal Cancer Liver Metastases.; Journal of vascular and interventional radiology : JVIR; Vol 29(8). 2018 Aug.
• 1. Casabianca AS
  2. Shah MM
  3. Carpizo D
  Accessory bile duct: a rare but important anatomical variant.; BMJ case reports; Vol 2018. 2018 Jun 17.
• 1. Kogan S
  2. Carpizo DR
  Zinc Metallochaperones as Mutant p53 Reactivators: A New Paradigm in Cancer Therapeutics.; Cancers; Vol 10(6). 2018 May 29.
• 1. Shimada K
  2. Reznik E
  3. Stokes ME
  4. Krishnamoorthy L
  5. Bos PH
  6. Song Y
  7. Quartararo CE
  8. Pagano NC
  9. Carpizo DR
  10. deCarvalho AC
  11. Lo DC
  12. Stockwell BR
  Copper-Binding Small Molecule Induces Oxidative Stress and Cell-Cycle Arrest in Glioblastoma-Patient-Derived Cells.; Cell chemical biology; Vol 25(5). 2018 May 17.
• 1. NeMoyer RE
  2. Shah MM
  3. Hasan O
  4. Nosher JL
  5. Carpizo DR
  A novel combined interventional radiologic and hepatobiliary surgical approach to a complex traumatic hilar biliary stricture.; International journal of surgery case reports; Vol 44. 2018.
• 1. Tsang AT
  2. Dudgeon C
  3. Yi L
  4. Yu X
  5. Goraczniak R
  6. Donohue K
  7. Kogan S
  8. Brenneman MA
  9. Ho ES
  10. Gunderson SI
  11. Carpizo DR
  U1 Adaptors Suppress the KRAS-MYC Oncogenic Axis in Human Pancreatic Cancer Xenografts.; Molecular cancer therapeutics; Vol 16(8). 2017 Aug.
• 1. Cercek A
  2. Gendel V
  3. Jabbour S
  4. Moore D
  5. Chen C
  6. Nosher J
  7. Capanu M
  8. Chou JF
  9. Boucher T
  10. Kemeny N
  11. Carpizo DR
  A Comparison of Yttrium-90 Microsphere Radioembolization to Hepatic Arterial Infusional Chemotherapy for Patients with Chemo-refractory Hepatic Colorectal Metastases.; Current treatment options in oncology; Vol 18(7). 2017 Jul.
• 1. Yu X
  2. Blanden A
  3. Tsang AT
  4. Zaman S
  5. Liu Y
  6. Gilleran J
  7. Bencivenga AF
  8. Kimball SD
  9. Loh SN
  10. Carpizo DR
  Thiosemicarbazones Functioning as Zinc Metallochaperones to Reactivate Mutant p53.; Molecular pharmacology; Vol 91(6). 2017 Jun.
• 1. Kogan S
  2. Carpizo D
  Pharmacological targeting of mutant p53.; Translational cancer research; Vol 5(6). 2016 Dec.
• 1. Eng OS
  2. Arlow RL
  3. Moore D
  4. Chen C
  5. Langenfeld JE
  6. August DA
  7. Carpizo DR
  Fluid administration and morbidity in transhiatal esophagectomy.; The Journal of surgical research; Vol 200(1). 2016 Jan.